한국어
English
日本語
中文(简体)
Rapalobel 2 mg (Sirolimus) Tablets
2mg
Prescription medication
Jongkundang Co., Ltd.
Sirolimus is an ingredient that prevents rejection after transplantation through immunosuppressive action.
MFDS ingredient code M096307
Sirolimus is a drug belonging to the immunosuppressant class, primarily used in organ transplant patients to suppress immune responses, thus treating graft-versus-host disease and autoimmune diseases. This ingredient plays a role in regulating the excessive activation of the immune system.
Sirolimus inhibits specific protein complexes within immune cells, blocking the proliferation and activation of immune cells. By doing this, it prevents the immune system from attacking the transplanted organ, thus preventing rejection.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other immunosuppressants, sirolimus targets the mTOR pathway to regulate the growth and proliferation of immune cells. As a result, it has a different mechanism of action compared to traditional calcineurin inhibitors, and its side effect profile also differs.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
